/Investor DB

Lake Bleu Capital — Full Portfolio

2 tracked investments · listed companies and verified rows first

Insilico Medicineinsilico.comin𝕏Sep 2019✓ verified

Insilico Medicine uses artificial intelligence to discover and develop new drugs, operating an AI-driven platform for pharmaceutical research and development.

AI & Machine LearningBiotechDigital HealthHealthtechHong Kong, US

Aleksandrs Zavoronkovs(Executive Officer, Director)Alex Zavoronkov(Director)Alex Zhavoronkov(Founder)inAlex Aliper(President)inFeng Ren(Chief Scientific Officer, Executive Director & Co-CEO)in

BoardNisa Leung(Director)in

Co-investorsLilly Asia VenturesOrbiMedQiming Venture PartnersWarburg PincusBaidu VenturesEight Roads Ventures+16 more

Singleron Biotechnologiessingleronbio.comin𝕏Nov 2021

Singleron Biotechnologies develops single-cell and single-nucleus sequencing kits and solutions for transcriptome analysis of biological samples.

BiotechMedical DevicesCologne, DE

Nan Fang(PhD, MBA; CEO and Founder)inJing Zhou(PhD; CSO (co-founder))inRong Fan(Co-Founder of Singleron, Professor Yale University)in

Co-investorsARCH Venture PartnersLAVLilly Asia VenturesMSA CapitalSBCVCSherpa Healthcare Partners+1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.